Latest Breaking News On - Biogen idec - Page 27 : comparemela.com

Global Pharma, Biotech & Diagnostics Co-promotion and Co-marketing Deals Report 2021: Comprehensive Access and Analysis of 350+ Deals

/PRNewswire/ The "Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2021" report has been added to.

Eli lillyKyowa hakkoAcceleron pharmaLaura woodSecurities exchange commissionOffice hours callIronwood pharmaceuticalsE st office hours callBiogen idecCo marketing partnering termsGlobal co promotionTopics coveredSenior managerFree callHours callResearch and markets

Global Pharma, Biotech and Diagnostics Option and Evaluation Deals Report/Directory 2021: Company A-Z, Headline Value, Stage of Development at Signing, Therapeutic Area, Technology Type

/PRNewswire/ The "Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021" report has been added to.

Progentix orthobiologyViropharma meritage pharmaLaura woodSecurities exchange commissionIdenix pharmaceuticalsOffice hours callEvaluation partnership termsIsis pharmaceuticalsE st office hours callBiogen idecJanssen pharmaceuticalsOncogenex pharmaceuticalsGlobal optionEvaluation partnering termsTopics coveredFree call

Global Manufacturing and Supply Partnering Terms and Agreements Deals in Pharma, Biotech and Diagnostics Report 2021: Identify the Most Active Manufacturing and Supply Dealmakers Since 2014

/PRNewswire/ The "Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021" report has been added to.

Agenus bioCatalent pharmaAsahi kaseiEli lillyKyowa hakkoLaura woodEndo pharmaceuticalsOmthera pharmaceuticalsOffice hours callE st office hours callBiogen idecAuxilium pharmaceuticalsOrexigen therapeuticsSupply partnering termsGlobal manufacturingTopics covered

Global Pharma, Biotech and Diagnostics Asset Purchase Partnering Directory 2014-2021: Focus on Business Assets, Product Assets, Royalty Assets, & Technology Assets

/PRNewswire/ The "Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2021" report has been added to.

Eli lillyKyowa hakkoLaura woodOffice hours callE st office hours callBiogen idecBiotime acquisition geron corporationValeant pharmaceuticalsAsset purchase partnering termsGlobal asset purchase dealsAsset purchase dealsTopics coveredAsset purchaseBiotime acquisitionSenior managerFree call

Tech Moves: Athira Pharma adds Wave Life Sciences CMO Michael Panzara to board

Tech Moves: Athira Pharma adds Wave Life Sciences CMO Michael Panzara to board
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

Athira pharmaSanofi genzymeMichael panzaraWave life sciences photoBiogen idecHarvard medical schoolWave life sciencesHarvard medicalGrant pickering